Table 3 Pyridinoline (PYD μg/g creatinine) and Deoxypyridinoline (DPYD μg/g creatinine), Bone specific alkaline phosphatase (BAP μg/l).
From: Treatment of bone loss in patients with chronic liver disease awaiting liver transplantation
PYD (μg/g creatinine) | IBA | P-value vs. Pre-LT | DPYD (μg/g creatinine) | IBA | P-value vs. Pre-LT |
|---|---|---|---|---|---|
Pre-LT | 311±180 | - | Pre-L | 46.1±28.2 | - |
3 months | 301±118 | 0.51 | 3 months | 35.4±14.0 | 0.44 |
6 months | 317±146 | 0.31 | 6 months | 42.8±19.5 | 0.49 |
12 months | 220±62 | 0.18 | 12 months | 33.4±17.4 | 0.75 |
24 months | 169±54 | 0.18 | 24 months | 32.2±15.6 | 0.65 |
BAP (μg/l) | IBA | p-value vs. Pre-LT | |||
Pre-LT | 18.6±8.7 | - | |||
3 months | 10.0±3.9 | 0.016* | |||
6 months | 12.2±3.9 | 0.022* | |||
12 months | 14.9±5.8 | 0.08 | |||
24 months | 15.0±7.7 | 0.63 | |||